|
2024 Conference Publication Sodium intake of adults with cystic fibrosis living in north Queensland post elexacaftor-tezacaftor-ivacaftorHerd, Karen, Matson, Angela, Loel, Felicity, Moore, Vanessa and Evans, Ieuan (2024). Sodium intake of adults with cystic fibrosis living in north Queensland post elexacaftor-tezacaftor-ivacaftor. 15th Australasian Cystic Fibrosis Conference, Brisbane, QLD, Australia, 2–4 August 2024. Richmond, VIC, Australia: John Wiley & Sons. |
|
2024 Conference Publication Multi-centre experience of elexacaftor-tezacaftor-ivacaftor use in adult cystic fibrosis transplant recipients in QueenslandWood, Michelle, Smith, Iain, Hiscock, Keirran, Smith, Daniel, Keating, Rebecca, Burr, Lucy, Tay, George, Zimmerman, Maureen, Feather, Iain, Cobb, Robyn, Moore, Vanessa, Evans, Ieuan, Reid, David, Masel, Philip, Mackintosh, John and Henderson, Daniel (2024). Multi-centre experience of elexacaftor-tezacaftor-ivacaftor use in adult cystic fibrosis transplant recipients in Queensland. 15th Australasian Cystic Fibrosis Conference, Brisbane, QLD Australia, 2-4 August 2024. Richmond, VIC Australia: John Wiley & Sons. |
|
2024 Conference Publication Evaluating the outcomes of CFTR modulator therapy on the rates of non-tuberculous mycobacteria isolated from patients in a cystic fibrosis (CF) cohortEvans, Ieuan Edward Shepherd, Smith, Daniel and Reid, David William (2024). Evaluating the outcomes of CFTR modulator therapy on the rates of non-tuberculous mycobacteria isolated from patients in a cystic fibrosis (CF) cohort. 15th Australasian Cystic Fibrosis Conference, Brisbane, QLD Australia, 2–4 August 2024. Richmond, VIC Australia: John Wiley & Sons. |
|
2023 Journal Article Paraquat ingestion in an adult with cystic fibrosis (CF): Diagnostic and management dilemmasEvans, Ieuan E. S., Kumar, Shanal, France, Megan, Smith, Daniel, Masel, Philip, Tay, George, Henderson, Daniel, Bell, Scott C. and Reid, David (2023). Paraquat ingestion in an adult with cystic fibrosis (CF): Diagnostic and management dilemmas. Respirology Case Reports, 11 (12) e01235, 1-4. doi: 10.1002/rcr2.1235 |
|
2021 Journal Article Stepwise pathogenic evolution of Mycobacterium abscessusBryant, Josephine M., Brown, Karen P., Burbaud, Sophie, Everall, Isobel, Belardinelli, Juan M., Rodriguez-Rincon, Daniela, Grogono, Dorothy M., Peterson, Chelsea M., Verma, Deepshikha, Evans, Ieuan E., Ruis, Christopher, Weimann, Aaron, Arora, Divya, Malhotra, Sony, Bannerman, Bridget, Passemar, Charlotte, Templeton, Kerra, MacGregor, Gordon, Jiwa, Kasim, Fisher, Andrew J., Blundell, Tom L., Ordway, Diane J., Jackson, Mary, Parkhill, Julian and Floto, R. Andres (2021). Stepwise pathogenic evolution of Mycobacterium abscessus. Science, 372 (6541) eabb8699, 1-13. doi: 10.1126/science.abb8699 |
|
2019 Journal Article Microbiological evaluation of UV disinfection effectiveness in a specialist cystic fibrosis clinicAllen, O., Jadkauskaite, L., Shafi, N.T., Jackson, A., Athithan, V., Chiu, Y.-D., Evans, I.E.S., Floto, R.A. and Haworth, C.S. (2019). Microbiological evaluation of UV disinfection effectiveness in a specialist cystic fibrosis clinic. Journal of Cystic Fibrosis, 18 (4), e37-e39. doi: 10.1016/j.jcf.2019.04.019 |
|
2017 Journal Article Bronchiectasis severity is an independent risk factor for vascular disease in a bronchiectasis cohortEvans, Ieuan Edward Shepherd, Bedi, Pallavi, Quinn, Tom M. and Hill, Adam T. (2017). Bronchiectasis severity is an independent risk factor for vascular disease in a bronchiectasis cohort. Chest, 151 (2), 383-388. doi: 10.1016/j.chest.2016.09.022 |
|
2013 Journal Article NSAIDs and nephrocalcinosisEvans, Ieuan, Penman, Ian, Turner, Neil and Dhaun, Neeraj (2013). NSAIDs and nephrocalcinosis. European Journal of Clinical Pharmacology, 69 (12), 2103-2104. doi: 10.1007/s00228-013-1569-6 |
